Hikma Adds Six Celltrion Biosimilars To Considerable MENA Partnership

Likely Biosimilars Include Omalizumab, Denosumab And Aflibercept

 
• By Dean Rudge
  
Six hands with thumbs up
• Source: Shutterstock

More from Deals

More from Business